Introduction

1
Asthma is the most common chronic disorder in childhood, and asthma exacerbation is 2 an important cause of childhood morbidity and hospitalization. The prevalence of 3 childhood asthma in Japan is 5.1% among infants, 6.4% among children and 3.2% 4 among adults, and 1.146 million patients received ongoing medical care for asthma in 5 1996 [1] . Costs for treatment of asthma have great financial impact on health care 6 worldwide. It was reported that the number of disability-adjusted life years lost due to 7 asthma worldwide is similar to that for diabetes, liver cirrhosis or schizophrenia [2] . 8 Asthma is a chronic airway inflammatory disease caused by infiltration of 9 lymphocytes, mast cells and eosinophils into the airways, and T-helper type 2 cytokines 10 play crucial roles in orchestrating the inflammatory responses [3] . Factors that influence 11 asthma exacerbation include infections, such as those by Rhinovirus, Chlamydia and
12
Mycoplasma species, and exposure to sensitized allergens [4] [5] [6] . However, the 13 molecular mechanisms that underlie asthma exacerbation are only partially understood.
Two types of tissues have been used for human microarray studies of asthma.
1
One is airway epithelium cells from patients and healthy subjects. Laprise et al. [7] 2 performed microarray studies with tissue obtained from bronchial biopsies of 4 3 asthmatic patients before and after inhaled corticosteroid therapy and from those of 4 4 healthy subjects. Seventy-nine genes were differentially expressed between asthmatic 5 subjects and controls, including nitric oxide synthase 2A (NOS2A), glutathione 6 peroxidase 3 (GPX3), arachidonate 15-lipoxygenase (ALOX15), cystatin C (CTSC) and 7 chemokine (C-X3-C motif) receptor 1 (CX3CR1). Lilly et al. [8] reported that PBMCs from asthmatic patients may provide clues regarding the disease pathway.
7
In the present study, we performed microarray analysis to identify changes in 8 gene expression that reflect acute exacerbation of asthma and constructed a pathway of 9 the molecular changes that occur during asthma exacerbation. the US National Institutes of Health [3] . Asthmatic patients had to satisfy the following 7 2 criteria: (1) 2 or more episodes of wheezing and shortness of breath during the 8 previous 12 months and (2) reversibility of the wheezing and dyspnea, either 9 spontaneously or in response to bronchodilator treatment. Methacholine challenge 10 testing was not done because of the young ages of the asthma patients; however, 11 differential diagnosis of asthma in the affected children was made by participating 12 pediatricians who had treated the children for more than 1 year, and they confirmed 13 each diagnosis of asthma. Total and specific IgE titers for Dermatophagoides farinae 14 were determined with the Pharmacia CAP System (Uppsala, Sweden). Children with 15 asthma exacerbation who required hospitalization (asthma exacerbation (AE) group) 16 and those with stable asthma without any exacerbation in at least the past 4 weeks 17 (stable asthma (SA) group) were enrolled in the study. All of the patients in AE group had episodes of progressive increasing coughing and wheezing. Responses to the initial 1 bronchodilator treatment were not prompt or sustained for more than 3 h, and no 2 improvement was observed more than 2 h after administration of intravenous steroids.
3
All of them were treated with 1mg/kg, 4 times/day of methylprednisolone for 1-3 days 4 (mean 2.3 ± 0.7 days) after hospitalization and with inhaled short acting beta-2 agonists 5 as combination therapy until their symptoms disappeared. Symptom such as wheezing 6 and dyspnea disappeared within a few days in all children, and maximum duration of 7 hospitalization was 7 days (mean 3.9 ± 1.8 days). Severity of asthma exacerbation in Table   8 1. 
Results
1
Our data processing strategy is outlined in Figure. We first identified transcripts that 
11
Therefore, our sample size was sufficient for the detection of genes having moderate 12 differences in expression, but it may not be enough for genes displaying small 13 difference in expression.
14 A total of 158 transcripts were up-regulated, and 31 transcripts were analyzed the genes that were differentially expressed during upper respiratory infection. Table 2 and supplementary Table   8 1, we randomly selected 6 samples each from the AE and SA groups 10 times and 9 performed the Welch's t-test (supplementary Table 2 responses to external stimuli (q < 0.05). However, these associations disappeared after 10 excluding the 62 infection-related genes (q > 0.05, Table 3 ).
Pathway analysis was used to identify networks of genes that interact expression of these genes was elevated during asthma exacerbation (P < 0.01, Table 5 ).
10
The differences in the expressions of the CD200 and Retinol binding protein 7 (RBP7)
11 genes between the IC and NC groups were not statistically significant (P > 0.05), while 12 S100 calcium-binding protein A9 (S100A9) and growth arrest-specific 6 (GAS6) were 13 highly up-regulated in the IC group (P < 0.01) relative to the expressions in the NC 14 group.
Discussion
1
In the present study, we performed microarray analysis to identify genes related to 2 asthma exacerbation in children, and identified 153 up/down-regulated genes during 3 asthma exacerbations. suggest that most asthma exacerbations are related to infections, or that asthma 9 exacerbation and respiratory infections share a common underlying mechanism.
10
There are a number of limitations to the present study. First, we used PBMCs, Second, since the sample size of the NC vs IC groups was small, the power to 6 detect the infection-related genes may be not sufficient. GO analysis ( suggesting that we had excluded some of the infection-related genes during analysis.
However, we cannot exclude the possibility that true infection-related genes were also 11 included in the remaining 91 transcripts. anti-inflammatory effects that are primarily mediated through the modulation of 17 pro-inflammatory gene expression and inflammatory cell functions [24] , and these were highly connected in the network analysis (Table 4 ). The role of RBP7 in immune 1 reactions has not yet been examined, and a further study is needed to elucidate the role 2 of RBP7 for immune responses.
3
In conclusion, the present study identified the genes related to asthma 4 exacerbation, and half of these genes were differentially regulated during respiratory 5 infection. We identified the asthma-exacerbation related genes that were not associated 6 with infection and some of these results were validated using RT-PCR. Although the 7 regulation and function of these genes in asthma are mostly unknown, these gene mechanisms that underlie asthma.
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